Anish John's Insider Trades & SAST Disclosures

Anish John's most recent trade in Oncocyte Corporation was a trade of 121,381 Option to Purchase Common Stock done . Disclosure was reported to the exchange on Feb. 24, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Oncocyte Corporation
Anish John Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2023 121,381 121,381 - - Option to Purchase Common Stock
Oncocyte Corporation
Anish John Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2023 250,466 250,466 - - Option to Purchase Common Stock
Oncocyte Corporation
Anish John Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Aug 2022 150,000 150,000 (0%) 0% 0 Common Stock, no par value
Oncocyte Corporation
Anish John Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Aug 2022 100,000 100,000 - - Option to Purchase Common Stock
Oncocyte Corporation
Anish John SVP, Finance, and Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 50,000 50,000 - - Option to Purchase Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades